Vivanza Biosciences has informed that the Board of Directors of the Company at its meeting held on Thursday, August 10, 2023 at Registered Office of the Company has considered and approved the Un-audited Standalone and Consolidated Financial Results along with Limited Review Report of the Company for the Quarter ended on 30th June, 2023. The meeting of Board of Directors of the Company commenced at 12:30 pm and concluded at 01:10 pm.
The above information is a part of company’s filings submitted to BSE.